BEAM logo

BEAM
Beam Therapeutics Inc

6,455
Mkt Cap
$3.32B
Volume
550,826.00
52W High
$36.44
52W Low
$15.35
PE Ratio
-31.84
BEAM Fundamentals
Price
$32.19
Prev Close
$32.34
Open
$31.59
50D MA
$27.30
Beta
1.86
Avg. Volume
2.14M
EPS (Annual)
-$0.8088
P/B
2.66
Rev/Employee
$273,469.67
$1,650.58
Loading...
Loading...
News
all
press releases
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates
Beam Therapeutics (BEAM) delivered earnings and revenue surprises of -4.60% and +52.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2h ago
News Placeholder
More News
News Placeholder
Beam Therapeutics Inc. Q1 Loss Declines
(RTTNews) - Beam Therapeutics Inc. (BEAM) reported Loss for first quarter of -$94.32 million...
Nasdaq News: Markets·4h ago
News Placeholder
Concurrent Investment Advisors LLC Invests $2.13 Million in Beam Therapeutics Inc. $BEAM
Concurrent Investment Advisors LLC acquired a new stake in Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and...
MarketBeat·8d ago
News Placeholder
Beam Therapeutics (BEAM) Projected to Post Earnings on Tuesday
Beam Therapeutics (NASDAQ:BEAM) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·9d ago
News Placeholder
Beam Therapeutics (NASDAQ:BEAM) Trading Up 8.4% - What's Next?
Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 8.4% - Still a Buy...
MarketBeat·10d ago
News Placeholder
Cathie Wood sells $75 of surging semiconductor stock
Cathie Wood, head of Ark Investment Management, often takes advantage of market swings.That's what she just did, selling shares of a semiconductor stock after it jumped 25% in a week.Last year...
TheStreet.com·11d ago
News Placeholder
Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.7% - What's Next?
Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 6.7% - Time to Sell...
MarketBeat·13d ago
News Placeholder
Cathie Wood buys $900,000 of surging megacap stock
Cathie Wood, chief of Ark Investment Management, likes to trade around earnings season.Sometimes, Wood adds or sells stocks right after their earnings. Sometimes, she makes moves days ahead of results, betting on potential gains. That's what she just did, buying shares of a megacap tech firm ahead...
TheStreet.com·15d ago
News Placeholder
Cathie Wood buys $2.5 million of tumbling megacap stock
Cathie Wood, head of Ark Investment Management, was relatively quiet this week, even as the S&P 500 rallied about 4.5% over the past five days.Wood made no trades on Tuesday, April 14, and Wednesday...
TheStreet.com·19d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Has $122.23 Million Stock Holdings in Beam Therapeutics Inc. $BEAM
Sumitomo Mitsui Trust Group Inc. cut its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM - Free Report) by 8.7% during the 4th quarter, according to its most recent filing with the...
MarketBeat·23d ago
<
1
2
...
>

Latest BEAM News

View
Top Discussions